《大行報告》摩通首予微盟(02013.HK)「增持」評級 目標價22元
摩根大通發表研究報告,首予微盟集團(02013.HK)「增持」評級,目標價22元。報告稱,去中心化商業模式為商戶就獲得用戶、客戶資料及建立關係帶來具成本效益解決方案。微盟正捕捉有關機遇,過去五年收入增長達十倍,成為領域內龍頭SaaS及市場推廣供應商。
報告表示,在行業利好及公司在滲透至大型高端客戶取得進展下,料2020至2025年間收入年均複合增長達30%,SaaS服務收入年均複合增長料更達49%。
摩通稱,公司股價自2月高位回調約50%,同期國指回調約10%,主因市場焦點由增長轉至價值導向,而不是公司基本面改變。今年首季強勁業績確認業務轉型進展穩固,料推動公司跑贏市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.